GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Accounts Receivable

Immunoclin (Immunoclin) Accounts Receivable : $0.07 Mil (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Immunoclin's accounts receivables for the quarter that ended in Oct. 2014 was $0.07 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Immunoclin's Days Sales Outstanding for the quarter that ended in Oct. 2014 was 1,222.75.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Immunoclin's Net-Net Working Capital per share for the quarter that ended in Oct. 2014 was $-0.09.


Immunoclin Accounts Receivable Historical Data

The historical data trend for Immunoclin's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Accounts Receivable Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Accounts Receivable
- 0.03 0.01

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.02 0.02 0.07

Immunoclin Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Immunoclin Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Immunoclin's Days Sales Outstanding for the quarter that ended in Oct. 2014 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.067/0.005*91
=1,222.75

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Immunoclin's accounts receivable are only considered to be worth 75% of book value:

Immunoclin's Net-Net Working Capital Per Share for the quarter that ended in Oct. 2014 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.146+0.75 * 0.067+0.5 * 0-2.84
-0.001-0)/28.8312
=-0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Immunoclin Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Immunoclin's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunoclin (Immunoclin) Business Description

Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines